Business EconomyPosted at: Feb 14 2025 8:10PM


VEKA takes 100 pc control of uPVC biz in Joint Venture NCL-VEKA

New Delhi, Feb 14 (UNI) Germany based VEKA on Friday said it has successfully acquired 100 per cent ownership of the Company, marking VEKA’s unwavering commitment to the Indian market and its confidence in India’s rapidly expanding construction, real estate, and infrastructure sectors.
With VEKA now holding 100 per cent control, following a takeover of the remaining 50 per cent stake previously held by NCL and other shareholders , company said in a release.
Since its launch in 2009, the company has become India’s largest producer of uPVC profiles for doors and windows. VEKA holds largest market share across 130 cities, with a strong product portfolio and a revenue of Rs 442 crores in 2024, maintaining its leadership in the uPVC window and door solutions sector.
Andreas Hartleif, CEO, VEKA AG Germany said, “With this strategic takeover, VEKA Germany has reaffirmed its long-term commitment to India, recognizing the country’s immense potential as a hub for innovation, manufacturing, and market growth. This move further strengthens VEKA's leadership in both global and Indian markets. As India’s economy experiences a robust growth, driven by rapid urbanization, an infrastructure boom, and a growing focus on sustainable housing, VEKA is well-positioned to capitalize on the rising demand for uPVC profiles in India."
Ashven Datla, Chairman of the Company said, “We look forward to a new phase of growth and success in the journey of VEKA in India, as VEKA Germany now assumes 100% ownership of the company. With plans to increase production capacity in line with the projected growth, with facilities that will serve as export hubs to international markets and explore greenfield opportunities, the Company is poised to expand further. Our continued focus on innovation and product development will help meet India’s growing demand for high-quality, energy-efficient uPVC solutions."
UNI SKB BM
Please log in to get detailed story.
Tags: #VEKA takes 100 pc control of uPVC biz in Joint Venture NCL-VEKA
More News

Brookfield, FedEx to set up GCCs in Mumbai

14 Dec 2025 | 1:39 AM

Mumbai, Dec 13 (UNI) Global alternative asset management and investment firm, Brookfield as well as FedEx Corporation plan to set up Asia’s largest global capability centre (GCC) in Mumbai, Maharashtra Chief Minister Devendra Fadnavis has announced.

see more..

Kerala boasts cost-effective ecosystem of space vendors: Experts at Huddle Global 2025

14 Dec 2025 | 1:02 AM

Thiruvananthapuram, Dec 13 (UNI) Kerala has a very cost-effective and mature ecosystem of space vendors that would help the country become a global vendor in the sector, said experts today at Huddle Global 2025.

see more..

AP: Ponduru Khadi from Srikakulam receives prestigious GI Tag

13 Dec 2025 | 8:22 PM

Srikakulam, (Andhra Pradesh), Dec 13 (UNI) After years of sustained efforts involving extensive documentation, meetings, and follow-ups, Ponduru Khadi, a traditional handwoven fabric from Srikakulam district, has been awarded the prestigious Geographical Indication (GI) tag, union Civil Aviation Minister Kinjarapu Ram Mohan Naidu on Saturday.
Ram Mohan Naidu, also a native of Srikakulam, expressed immense pride over the achievement.

see more..

SBI report flags marginal rise in inflation but sees comfort on prices and rates

13 Dec 2025 | 2:37 PM

New Delhi, Dec 13 (UNI) India’s retail inflation has shown a marginal reversal in November 2025 but remains at a comfortable level, with overall price pressures still muted, according to SBI Research’s latest Ecowrap report released on Saturday here.

see more..

Ozempic ® - world’s most prescribed GLP-1is now available in India

13 Dec 2025 | 4:02 AM

Hyderabad, Dec 12 (UNI) Novo Nordisk, a global healthcare company, on Friday announced the launch of its once-weekly diabetes drug Ozempic® (injectable semaglutide) in India, marking a significant addition to the country’s treatment options for type 2 diabetes.
The therapy, a GLP-1 receptor agonist, is approved as an adjunct to diet and exercise for adults with uncontrolled type 2 diabetes mellitus (T2DM).

see more..